We review our content at regular intervals and update it whenever new research or a change in clinical guidelines requires it.
| FIELD OF APPLICATION | DETAILS |
|---|---|
| Generic Name | Sodium oxybate |
| Active Ingredient | gamma-Hydroxybutyric acid salt |
| Drug Category | Neurology |
| Drug Class | Palliative treatment, Immunosuppressive therapy, Targeted therapy |
| Brand Names | Lumryz, Sodium Oxybate, Xyrem, Xywav |
| Dosage Forms | For suspension, extended release, For suspension, extended release; kit, Solution, Syrup |
| Route of Administration | Oral |
| FDA Approval Status | FDA Approved (July 2002) Approved |
Sodium oxybate: Overview
Sodium oxybate is a central nervous system (CNS) depressant and the sodium salt of gamma-hydroxybutyric acid (GHB), an endogenous cerebral inhibitory neurotransmitter and metabolite of GABA. It is indicated to treat symptoms of narcolepsy, specifically excessive daytime sleepiness (EDS) and cataplexy, which is a sudden conscious muscle weakness triggered by strong emotions. Because of its physiological effects and high potential for misuse, disinhibition, and abuse, it is heavily regulated as a controlled substance and accessible only through restricted distribution programs.
What Is Sodium oxybate & How Does It Work?
Sodium oxybate belongs to the class of organic compounds known as short-chain hydroxy acids and derivatives, which are hydroxy acids with an alkyl chain containing fewer than 6 carbon atoms. It is an acyclic monocarboxylic acid salt that functions natively as an endogenous cerebral neurotransmitter precursor.
The physiological actions of sodium oxybate are mediated by gamma-hydroxybutyrate (GHB), its active compound. At lower doses, GHB binds to high- and low-affinity G-protein-coupled GHB receptors, inducing the release of glutamate, an excitatory neurotransmitter. At higher therapeutic doses, GHB acts as an agonist at GABA-B receptors located on noradrenergic, dopaminergic, and thalamocortical neurons involved in sleep-wake regulation, attention, and vigilance. Furthermore, GHB metabolizes directly into GABA, which modulates GABA-A and GABA-C receptors to suppress central neuronal hyperexcitability, thereby stabilizing sleep architecture and preventing cataplexy.
Is Sodium oxybate FDA Approved?
Yes, Sodium oxybate is FDA Approved. It gained its initial FDA approval in July 2002 under the brand name Xyrem as an oral solution.
Subsequently, a fixed-dose combination product containing sodium, calcium, potassium, and magnesium oxybate (Xywav) was approved, followed by an extended-release oral suspension formulation marketed as Lumryz, which received full FDA approval in May 2023. In the United States and Europe, sodium oxybate is approved for pediatric and adult patients 7 years of age and older, whereas in Canada it is not recommended in children under 18 years unless clearly needed.
What Is Sodium oxybate Used For?
Sodium oxybate is prescribed for specific neurological disorders involving central sleep-wake dysregulation.
- Management of Cataplexy: Indicated as a prescription therapy to reduce the frequency and severity of cataplexy attacks in adult and pediatric patients with narcolepsy.
- Excessive Daytime Sleepiness (EDS): Prescribed in immediate-release solutions or extended-release oral suspensions to treat excessive daytime sleepiness associated with narcolepsy.
- Alcohol Withdrawal Syndrome (Investigational): Investigated and utilized internationally in select countries to aid abstinence maintenance in patients with alcohol use disorder.
Before Taking Sodium oxybate: Contraindications & Precautions
Because sodium oxybate is a potent central nervous system depressant, prescribers must strictly evaluate its use in approved countries, where it is available only through a restricted program for safety reasons. Misuse or improper administration can lead to severe complications.
Who Should Not Take Sodium Oxybate?
Sodium oxybate usage must be carefully evaluated regarding patient age. In the US and Europe, the drug is approved for use in patients seven years of age and older, while in Canada, it is not recommended in children under the age of eighteen, unless clearly needed.
Sodium oxybate: Pregnancy & Fertility
The compound belongs to the class of organic compounds known as short-chain hydroxy acids and derivatives. These are hydroxy acids with an alkyl chain containing less than six carbon atoms. Its reproductive safety profile is continuously evaluated.
Tell Your Doctor Before Taking Sodium oxybate
Inform your physician if you are using other central nervous system depressants or anesthetics. Due to its physiological effects, sodium oxybate is associated with a risk for substance misuse and abuse, including as a party drug.
Sodium oxybate: Dosage & Administration
Due to its profound sedating effects, sodium oxybate must be administered strictly while the patient is in bed.
Standard Sodium oxybate Dosing
Prescription products are available in specific dosage strengths. Sodium Oxybate Solution and Xyrem are formulated as a half gram per milliliter solution. Lumryz is available as an extended release suspension kit containing four and a half grams, six grams, and seven and a half grams. Mixture products like Xywav contain sodium oxybate alongside calcium, potassium, and magnesium oxybate.
How Sodium oxybate Is Administered
Sodium oxybate is administered orally using approved solution, syrup, or extended release suspension formats. It is a controlled substance available only through a restricted program. The extended-release suspension formulation gained tentative FDA approval in July 2022 and full approval in May 2023.
Sodium oxybate: Clinical Efficacy & Research
Clinical trials demonstrate that sodium oxybate significantly reduces daytime sleepiness and decreases the frequency of cataplexy attacks in narcoleptic patients. By stimulating GABAB receptors at noradrenergic and dopaminergic neurons, as well as thalamocortical neurons, it directly modulates sleep-wake regulation, attention, and vigilance. Furthermore, in some countries, sodium oxybate has been extensively investigated and successfully used in alcohol withdrawal syndrome to aid abstinence maintenance in alcohol use disorders.
Sodium oxybate: Side Effects & Safety Profile
Sodium oxybate carries a central Black Box Warning regarding central nervous system depression, respiratory depression, and high potential for abuse and misuse. Because of these severe risks, it is restricted under a Risk Evaluation and Mitigation Strategy (REMS) program.
Sodium oxybate carries significant warnings regarding central nervous system depression, abuse potential, and respiratory failure.
Common Sodium oxybate Side Effects
Adverse reactions relate to its classification as a central nervous system depressant. It has been misused to stimulate body growth and euphoria.
Serious Sodium oxybate Adverse Events
Adverse events involve severe risks for substance misuse and abuse. It is misused to induce disinhibition and sexual arousal as a party drug.
Managing Sodium oxybate Side Effects
Patients experiencing adverse effects from this controlled substance must be evaluated. For safety reasons, sodium oxybate is available only through a restricted program in approved countries.
Sodium oxybate: Interactions & What to Avoid
Combining sodium oxybate with other sedating agents significantly compounds the risk of fatal central nervous system depression.
Sodium oxybate: Interactions
Co-administration with central nervous system agents requires caution. It is the sodium salt of gamma-hydroxybutyric acid, an endogenous cerebral inhibitory neurotransmitter, and a metabolite of the inhibitory neurotransmitter GABA. Concomitant use of unregulated central nervous system depressants or anesthetics should be monitored.
Sodium oxybate: Food & Alcohol
Alcohol must be avoided during therapy with sodium oxybate. In some countries, it is investigated and used in alcohol withdrawal syndrome to aid abstinence maintenance in alcohol use disorders.
Sodium oxybate: Missed Dose, Overdose & Storage
Strict adherence to bedtime administration and secure storage protocols is vital to prevent accidental poisoning or diversion.
Missed Dose of Sodium oxybate
If a dose is missed, patients should skip it and not take it after waking; resume the normal schedule tomorrow. The extended-release oral suspension formulation gained tentative FDA approval in July 2022 and was fully approved in May 2023.
Sodium oxybate: Overdose & Emergency
Sodium oxybate overdose causes severe central nervous system depression, respiratory depression, and deep coma. Because its actions are mediated by gamma-hydroxybutyrate, its active compound, emergency medical care, requires immediate supportive intensive care.
How to Store Sodium oxybate
Store oral solutions and suspensions securely at controlled room temperature. The medication must be kept strictly out of the reach of children and unauthorized individuals to prevent accidental ingestion, misuse, or diversion. For safety reasons, it is only available through a restricted program.
Sodium oxybate: Patient Management & Monitoring
Because of restricted distribution requirements, patient care involves comprehensive registration and ongoing clinical monitoring.
Tests Before Starting Sodium oxybate
Prior to initiating therapy, providers must evaluate age appropriateness. It is approved in the US for patients seven and older; in Canada, it is not recommended in children under eighteen unless clearly needed.
Monitoring During Sodium oxybate Treatment
Clinicians must monitor patients for changes in daytime sleepiness and cataplexy attacks. Given its association with a risk for substance misuse as a party drug, continuous monitoring is strictly required.
Sodium oxybate: Do’s and Don’ts
- Do take your dose while sitting in bed and lie down immediately afterward.
- Don’t consume alcohol or take other sleep medications while using sodium oxybate.
Frequently Asked Questions
What is Sodium oxybate used to treat?
Sodium oxybate is used to treat cataplexy and excessive daytime sleepiness in patients with narcolepsy.
Is Sodium oxybate FDA approved?
Yes, Sodium oxybate was first FDA approved in July 2002 under the brand name Xyrem, with additional formulations like Lumryz approved in May 2023.
Why is Sodium oxybate a strictly controlled substance?
Because it is the sodium salt of GHB, it carries a high risk for central nervous system depression, misuse, abuse, and illicit use as a “club drug”.
Does Sodium oxybate have an FDA Black Box Warning?
Yes, it carries a Black Box Warning for central nervous system depression, respiratory depression, and abuse/misuse potential.
What forms is Sodium oxybate available in?
Prescription products are available in specific dosage strengths. Sodium Oxybate Solution and Xyrem are solutions. Lumryz is available as an extended release suspension kit. Mixture products like Xywav are available.
Can children take Sodium oxybate?
In the US and Europe, it is approved for pediatric patients 7 years of age and older, whereas in Canada it is generally restricted to patients 18 and older.
What happens if Sodium oxybate is taken with alcohol?
Taking it with alcohol can cause severe, potentially fatal respiratory depression and profound central nervous system collapse.
References
- DrugBank Online. Sodium oxybate (DB09072).
- U.S. Food and Drug Administration (FDA). Xyrem (sodium oxybate) Prescribing Information.
- National Center for Biotechnology Information (NCBI). PubChem Compound Summary: Sodium Oxybate.
Legal Disclaimer
The information provided is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider at any hospital or any local clinic before starting or stopping any medication.
